E ratio of 23.46.Based on the recent corporate insider activity of 61 insiders, corporate insider sentiment is negative on the stock.
https://www.tipranks.com/news/blurbs/needham-sticks-to-its-hold-rating-for-amphastar-pharmaceuticals-amph-2?utm_source=advfn.com&utm_medium=referral
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Amphastar Pharmaceuticals Charts.
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Amphastar Pharmaceuticals Charts.